22nd Century Operating Income 2011-2025 | XXII
22nd Century operating income from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
22nd Century Annual Operating Income
(Millions of US $) |
| 2024 |
$-14 |
| 2023 |
$-45 |
| 2022 |
$-34 |
| 2021 |
$-28 |
| 2020 |
$-19 |
| 2019 |
$-24 |
| 2018 |
$-24 |
| 2017 |
$-13 |
| 2016 |
$-11 |
| 2015 |
$-12 |
| 2014 |
$-12 |
| 2013 |
$2 |
| 2012 |
$-3 |
| 2011 |
$-4 |
| 2010 |
$-1 |
22nd Century Quarterly Operating Income
(Millions of US $) |
| 2025-03-31 |
$-3 |
| 2024-12-31 |
$-4 |
| 2024-09-30 |
$-3 |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-4 |
| 2023-12-31 |
$-14 |
| 2023-09-30 |
$-8 |
| 2023-06-30 |
$-12 |
| 2023-03-31 |
$-10 |
| 2022-12-31 |
$0 |
| 2022-09-30 |
$-15 |
| 2022-06-30 |
$-10 |
| 2022-03-31 |
$-8 |
| 2021-12-31 |
$-9 |
| 2021-09-30 |
$-8 |
| 2021-06-30 |
$-7 |
| 2021-03-31 |
$-5 |
| 2020-12-31 |
$-6 |
| 2020-09-30 |
$-4 |
| 2020-06-30 |
$-5 |
| 2020-03-31 |
$-4 |
| 2019-12-31 |
$-6 |
| 2019-09-30 |
$-8 |
| 2019-06-30 |
$-5 |
| 2019-03-31 |
$-5 |
| 2018-12-31 |
$-6 |
| 2018-09-30 |
$-6 |
| 2018-06-30 |
$-7 |
| 2018-03-31 |
$-5 |
| 2017-12-31 |
$-4 |
| 2017-09-30 |
$-3 |
| 2017-06-30 |
$-3 |
| 2017-03-31 |
$-3 |
| 2016-12-31 |
$-3 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-3 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
$-3 |
| 2015-09-30 |
$-3 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
$-4 |
| 2014-12-31 |
$-6 |
| 2014-09-30 |
$-3 |
| 2014-06-30 |
$-2 |
| 2014-03-31 |
$-1 |
| 2013-12-31 |
$6 |
| 2013-09-30 |
$-1 |
| 2013-06-30 |
$-2 |
| 2013-03-31 |
$-1 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-1 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.003B |
$0.024B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
